Vendor Intelligence Report: Peptide Worldwide

Executive summary

Across 1 Finnrick lab test, Peptide Worldwide is 1 pass / 0 fail, for a 100% overall pass rate. The record covers only Retatrutide, where the single independent result is positive but thin. For Retatrutide specifically, that is better than no data; for any other peptide, current PeptiLab purchase, or future lot, it should not be inherited as proof.

The larger issue is channel continuity. The double-d domain supplied to Finnrick did not resolve, while the historic single-d Peptide Worldwide domain is preserved in archives but returned HTTP 503 during the field run. Archived Peptide Worldwide pages and active PeptiLab surfaces point back to FIFTY FIFTY SEVEN LTD, giving buyers a real corporate anchor but not a clean canonical buying path.

That corporate anchor has limits. The UK entity uses a mass-registration virtual-office address, and the report found no verifiable manufacturer, facility certificate, Colorado warehouse record, or batch-linking mechanism behind the USA-made, WHO/GMP, ISO, and 99%+ purity claims. Archived checkout guidance also warned buyers that statements could show GLOBAL MUSCLE X or GLOBAL KETO X, descriptors that did not map to public entities.

Reputation evidence worsens after the rebrand: early Reddit discussion was mostly due-diligence chatter, while the PeptiLab period produced downtime, non-delivery, refund-friction reports, and a small but negative Trustpilot snapshot. The full report separates the narrow Retatrutide pass from successor-brand recourse risk.

Inside the full report:

• Appendix A — Finnrick Laboratory Data for the single Retatrutide test and methodology-divergence visuals
• Wayback timeline separating peptideworldwidde.com, peptideworldwide.com, peptideworldwide.com.au, and PeptiLab domains
• Companies House records for FIFTY FIFTY SEVEN LTD, Thomas Foley, PEPTILAB LTD, and ZYRATECH LTD
• Claim review for USA-made, WHO/GMP, ISO 9001:2008, 99%+ purity, Colorado warehouse, and COA-gallery evidence
• Payment-risk analysis of GLOBAL MUSCLE X and GLOBAL KETO X statement descriptors
• Reddit, Trustpilot, and affiliate-scan review of delivery and promotion signals

Risk assessment

• Limited independent testing coverage — medium: Peptide Worldwide has 1 Finnrick test (1 pass / 0 fail), only for Retatrutide; other products and current PeptiLab-successor purchases should not inherit that result.
• Brand churn and official-channel confusion risk — high: The briefed double-d domain does not resolve, the historic single-d domain returns 503, and the operation moved across multiple PeptiLab domains without a stable canonical channel.
• Non-delivery and service-continuity risk — high: Reddit and Trustpilot evidence describe PeptiLab downtime, unfulfilled orders, refund silence, and a 2.4/5 TrustScore on 14 reviews.
• Corporate and physical-operations opacity risk — medium: FIFTY FIFTY SEVEN LTD is identifiable, but uses a mass-registration virtual office and discloses no warehouse, laboratory, manufacturer, or operating site.
• Payment obfuscation risk — medium: Archived FAQ warned that card statements would show GLOBAL MUSCLE X or GLOBAL KETO X, and no public company/domain mapped to those descriptors.
• Unverifiable manufacturing and COA-claim risk — medium: USA-made, WHO/GMP, ISO 9001:2008, 99%+ purity, and Colorado-warehouse claims lack disclosed facility, certificate, or batch-link evidence.